Intuitive Surgical (ISRG) Stock
Leader in robotic surgery with high margin recurring revenue. Here's the price, business snapshot, and what's worth knowing about Intuitive Surgical in September 2026.
Intuitive Surgical (ISRG) is the dominant name in robotic-assisted surgery, best known for its da Vinci surgical systems that enable minimally invasive procedures. With a sizeable installed base and recurring revenue from instruments, accessories and service contracts, the company has built a high-margin business that benefits as hospitals upgrade systems and expand robotic programmes. Key growth drivers include wider clinical adoption across specialties, new product introductions and expansion into less invasive procedures. Investors should weigh these opportunities against concentration risks — substantial reliance on a single product family, ongoing R&D spending, regulatory and reimbursement dynamics, and sensitivity to hospital capital budgets. Competition from established medical groups and new robotics entrants is rising. The market cap (~$165.9bn) reflects premium expectations of persistent growth and margin expansion; such expectations can reverse. This overview is educational and not investment advice — consider your risk tolerance and seek personalised guidance before acting.
Why It’s Moving
ISRG holds investor attention as strong quarterly results keep the growth story intact
- Analysts remain upbeat after Intuitive Surgical’s latest quarter showed stronger-than-expected revenue and profit, reinforcing confidence in demand for its robotic surgery platforms.
- Procedure growth and recurring revenue from instruments, accessories, and services continue to support the company’s earnings profile, helping offset concerns that new robot sales have cooled.
- Recent commentary has focused on whether the stock’s pullback reflects a reset in expectations rather than a deterioration in fundamentals, with analysts still highlighting the company’s growth runway.
ISRG holds investor attention as strong quarterly results keep the growth story intact
- Analysts remain upbeat after Intuitive Surgical’s latest quarter showed stronger-than-expected revenue and profit, reinforcing confidence in demand for its robotic surgery platforms.
- Procedure growth and recurring revenue from instruments, accessories, and services continue to support the company’s earnings profile, helping offset concerns that new robot sales have cooled.
- Recent commentary has focused on whether the stock’s pullback reflects a reset in expectations rather than a deterioration in fundamentals, with analysts still highlighting the company’s growth runway.
Sixth Month Growth Performance
When is the next earnings date for INTUITIVE SURGICAL INC (ISRG)?
The next earnings date for ISRG is October 20, 2026, based on the current estimate and historical reporting pattern. This release is expected to cover Q3 2026 results. The date has not yet been formally confirmed by the company, so it remains subject to change.
Stock Performance Snapshot
Analyst Rating
Analysts recommend buying Intuitive Surgical's stock with a target price of $548.39, indicating strong growth potential.
Financial Health
Intuitive Surgical is performing well with strong revenue, profits, and cash flow generation.
Dividend
Intuitive Surgical does not currently pay a dividend, which could be due to reinvesting profits to fuel growth. If you invested $1000, you would receive $0 a year in dividends.
Why You’ll Want to Watch This Stock
Recurring revenue model
Consumables and service contracts create predictable follow-on sales, though hospital budgets and procedure volumes can affect revenue.
Innovation and R&D
Regular product updates and new platforms can open markets, but they require heavy R&D and face regulatory hurdles.
Global adoption trends
Growing use of minimally invasive surgery offers a large addressable market, yet adoption and reimbursement vary by region.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
